Skip to main content
Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.2510
-0.0338 (-11.87%)
At close: Nov 13, 2026, 4:00 PM EST
0.2718
+0.0208 (8.29%)
After-hours: Nov 13, 2026, 5:36 PM EST

Traws Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-2.790.230.230.230.23
Revenue Growth
-1134.51%0%0%0%-2.17%
Gross Profit
-2.790.230.230.230.23
Operating Income
-21.54-17.88-24.91-20.3-19.63-16.5
Net Income
-16.446.87-54.67-18.95-18.96-16.16
Earnings Per Share
-1.470.83-35.21-22.57-22.75-24.01
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
5.023.8221.3420.8238.7655.07
Net Cash Growth
-61.65%-82.10%2.48%-46.28%-29.62%189.46%
Net Cash Per Share
0.450.4613.7424.8046.3481.79
Cash & Investments
5.023.8221.3420.8238.7655.07

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16.85-18.19-29.79-17.93-16.29-19.49
Capital Expenditures
----0.01--
Free Cash Flow
-16.85-18.19-29.79-17.95-16.29-19.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--640.68%-11022.12%-8981.42%-8684.51%-7299.12%
Pretax Margin
-328.67%-73682.74%-8384.07%-8391.15%-7151.77%
Profit Margin
-246.06%-24192.03%-8384.07%-8391.15%-7151.77%
FCF Margin
--651.79%-13182.30%-7940.71%-7209.74%-8622.57%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-1.32----
Forward PE
-8.158.158.158.158.15
PS Ratio
-3.24142.7869.2959.79235.71